AU4344697A - Pharmaceutical compositions containing an mpl ligand - Google Patents
Pharmaceutical compositions containing an mpl ligandInfo
- Publication number
- AU4344697A AU4344697A AU43446/97A AU4344697A AU4344697A AU 4344697 A AU4344697 A AU 4344697A AU 43446/97 A AU43446/97 A AU 43446/97A AU 4344697 A AU4344697 A AU 4344697A AU 4344697 A AU4344697 A AU 4344697A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- mpl ligand
- mpl
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/524—Thrombopoietin, i.e. C-MPL ligand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72612396A | 1996-10-04 | 1996-10-04 | |
US08726123 | 1996-10-04 | ||
PCT/US1997/016196 WO1998014476A1 (en) | 1996-10-04 | 1997-09-12 | Pharmaceutical compositions containing an mpl ligand |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4344697A true AU4344697A (en) | 1998-04-24 |
Family
ID=24917340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43446/97A Abandoned AU4344697A (en) | 1996-10-04 | 1997-09-12 | Pharmaceutical compositions containing an mpl ligand |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2001501619A (en) |
KR (1) | KR100408229B1 (en) |
CN (1) | CN1142940C (en) |
AU (1) | AU4344697A (en) |
HK (1) | HK1024490A1 (en) |
TW (1) | TW561050B (en) |
WO (1) | WO1998014476A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8357513B1 (en) | 1994-01-03 | 2013-01-22 | Genentech, Inc. | Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof |
US5989538A (en) * | 1995-02-15 | 1999-11-23 | Amgen Inc. | Mpl ligand analogs |
IL149008A0 (en) * | 1999-10-04 | 2002-11-10 | Chiron Corp | Stabilized liquid polypeptide-containing pharmaceutical compositions |
US6495534B2 (en) | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
WO2002015926A1 (en) * | 2000-08-24 | 2002-02-28 | Kirin Beer Kabushiki Kaisha | c-mpl LIGAND-CONTAINING MEDICINAL COMPOSITIONS FOR INCREASING PLATELETS AND ERYTHROCYTES |
US7172905B2 (en) | 2001-08-07 | 2007-02-06 | The University Of Chicago | Polypeptide immobilization |
RU2354703C2 (en) * | 2002-12-13 | 2009-05-10 | Займодженетикс, Инк. | Producing il-21 in prokaryotic host cells |
RU2358440C2 (en) | 2003-07-07 | 2009-06-20 | Хилл`С Пет Ньютришн, Инк. | Composition for improved oxidising status of domestic animals |
AU2011265555B2 (en) * | 2006-04-21 | 2016-03-10 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
US9283260B2 (en) * | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
AU2014201388C1 (en) * | 2006-12-21 | 2017-02-02 | Amgen Inc. | Stable Buffered Formulations Containing Polypeptides |
CA2790018C (en) * | 2006-12-21 | 2015-02-03 | Amgen Inc. | Formulations |
CN102552184A (en) * | 2012-02-16 | 2012-07-11 | 山东泉港药业有限公司 | Thrombopoietin peptide analogue freeze-dried preparation |
MX2015003644A (en) | 2012-09-20 | 2015-09-25 | Morphosys Ag | Treatment for rheumatoid arthritis. |
MX2018015361A (en) * | 2016-06-16 | 2019-03-11 | Janssen Vaccines & Prevention Bv | Hiv vaccine formulation. |
US11241502B2 (en) * | 2017-11-16 | 2022-02-08 | Amgen Inc. | Stable compositions of pegylated carfilzomib compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874075A (en) * | 1993-10-06 | 1999-02-23 | Amgen Inc. | Stable protein: phospholipid compositions and methods |
EP0675201A1 (en) * | 1994-03-31 | 1995-10-04 | Amgen Inc. | Compositions and methods for stimulating megakaryocyte growth and differentiation |
CN1161468C (en) * | 1995-02-15 | 2004-08-11 | 安姆根有限公司 | MPL ligand analogs |
US6790439B1 (en) * | 1995-06-07 | 2004-09-14 | Zymogenetics, Inc. | Thrombopoietin compositions |
TW497972B (en) * | 1995-06-08 | 2002-08-11 | Kirin Brewery | Stable thrombopoietin (TPO)-containing lyophilized compositions |
US5879673A (en) * | 1996-01-25 | 1999-03-09 | Genentech, Inc. | Administration of thrombopoietin on a single day only |
-
1997
- 1997-09-12 AU AU43446/97A patent/AU4344697A/en not_active Abandoned
- 1997-09-12 JP JP10516562A patent/JP2001501619A/en active Pending
- 1997-09-12 CN CNB971802777A patent/CN1142940C/en not_active Expired - Fee Related
- 1997-09-12 WO PCT/US1997/016196 patent/WO1998014476A1/en active IP Right Grant
- 1997-09-12 KR KR10-1999-7002935A patent/KR100408229B1/en not_active IP Right Cessation
- 1997-09-26 TW TW086114078A patent/TW561050B/en not_active IP Right Cessation
-
2000
- 2000-06-22 HK HK00103786A patent/HK1024490A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1239480A (en) | 1999-12-22 |
CN1142940C (en) | 2004-03-24 |
KR100408229B1 (en) | 2003-12-01 |
WO1998014476A1 (en) | 1998-04-09 |
JP2001501619A (en) | 2001-02-06 |
HK1024490A1 (en) | 2000-10-13 |
TW561050B (en) | 2003-11-11 |
KR20000048905A (en) | 2000-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4762797A (en) | Pharmaceutical compositions | |
AU2967597A (en) | Pharmaceutical compositions | |
AU3049397A (en) | Cyclosporin-containing pharmaceutical composition | |
AU6740298A (en) | Pharmaceutical composition | |
AU5136998A (en) | Medicinal composition | |
AU4344697A (en) | Pharmaceutical compositions containing an mpl ligand | |
AU1574900A (en) | Pharmaceutical compositions containing insulin | |
AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
AU8107998A (en) | Pharmaceutical compositions | |
AU3777897A (en) | Pharmaceutical compositions | |
AU4326197A (en) | Pharmaceutical compositions | |
ZA9710272B (en) | Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds. | |
AU5317598A (en) | Novel pharmaceutical compositions | |
AU3089199A (en) | Preparations containing licariin | |
AU7904998A (en) | Pharmaceutical composition containing peptichemio | |
AU2531295A (en) | Pharmaceutical composition | |
AU4330097A (en) | Pharmaceutical compounds | |
AU5326298A (en) | Pharmaceutical compositions containing N-sulphonylindoline derivatives | |
AU3942297A (en) | Pharmaceutical compositions containing 4-oxobutanoic acids | |
AU9343098A (en) | Pharmaceutical composition | |
AU3410099A (en) | Pharmaceutical compositions containing melatonin inclusion complexes | |
AU3460897A (en) | Medicinal compositions | |
AU4169897A (en) | Pharmaceutical compounds | |
AU1509799A (en) | Pharmaceutical composition containing cyclosporin | |
AUPN862596A0 (en) | Pharmaceutical compositions |